2 results
Approved WMOWill not start
Primary ObjectiveSafety Lead-in* Evaluate the safety of a high-dose regimen of encorafenib + binimetinib combination therapy in patients with BRAFV600-mutant melanoma who have asymptomatic brain metastasisPhase 2If the high-dose regimen is…
Approved WMOPending
The primary objective is to examine the influence of assistive soft-robotic glove use on actual use of the arm and hand in daily life. Secondary objectives are to examine retention of the effect on arm use in daily life after cessation of assistive…